{"transactions":[{"id":687217,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-14T22:01:54.000Z","date":"2026-08-12","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":108.24,"value":541200.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by the John W. Childs 2013 Revocable Trust. The Reporting Person is Trustee of the John W. Childs 2013 Revocable Trust and may be deemed to hold voting and dispositive power with respect to these securities."}],"balance_after":194117,"source":{"system":"sec-edgar","filing":"0001628280-26-057196","document":"wk-form4_1786744911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000162828026057196/wk-form4_1786744911.xml","form_type":"4"}},{"id":687216,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-14T22:01:54.000Z","date":"2026-08-12","kind":"sale","planned":false,"acquired":false,"shares":80000,"price":107.23,"value":8578400.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $107.04 to $107.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by the John W. Childs 2013 Revocable Trust. The Reporting Person is Trustee of the John W. Childs 2013 Revocable Trust and may be deemed to hold voting and dispositive power with respect to these securities."}],"balance_after":199117,"source":{"system":"sec-edgar","filing":"0001628280-26-057196","document":"wk-form4_1786744911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000162828026057196/wk-form4_1786744911.xml","form_type":"4"}},{"id":687215,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-14T22:01:54.000Z","date":"2026-08-12","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":106.14,"value":1592100.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $105.77 to $106.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by the John W. Childs 2013 Revocable Trust. The Reporting Person is Trustee of the John W. Childs 2013 Revocable Trust and may be deemed to hold voting and dispositive power with respect to these securities."}],"balance_after":279117,"source":{"system":"sec-edgar","filing":"0001628280-26-057196","document":"wk-form4_1786744911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000162828026057196/wk-form4_1786744911.xml","form_type":"4"}},{"id":797218,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2026-05-01T00:07:52.000Z","date":"2026-04-28","kind":"grant","planned":false,"acquired":true,"shares":68693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2027 or (b) the date of the 2027 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":68693,"derivative":{"exercise_price":9.61,"expiration_date":"2036-04-28","underlying":"Common Shares","underlying_shares":68693},"source":{"system":"sec-edgar","filing":"0001027035-26-000008","document":"wk-form4_1777594070.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000102703526000008/wk-form4_1777594070.xml","form_type":"4"}},{"id":854430,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-03-09T22:12:05.000Z","date":"2025-03-04","kind":"purchase","planned":false,"acquired":true,"shares":28400,"price":30.4266,"value":864115.44,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment is being filed to correct the nature of the indirect ownership reported in the Form 4 filed on March 5, 2025 (the \"Original Form 4\"). The Original Form 4 inadvertently misstated that 3,400 Common Shares were indirectly acquired by the Reporting Person through the 2013 Charitable Remainder Trust, and 25,000 Common Shares were indirectly acquired by the Reporting Person through the John W Childs 2013 Revocable Trust. However, as reflected in this amendment, 28,400 Common Shares were indirectly acquired by the Reporting Person through the John W Childs 2013 Revocable Trust, and no Common Shares were indirectly acquired by the Reporting Person through the 2013 Charitable Remainder Trust."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.17 - $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.17 - $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2323971,"source":{"system":"sec-edgar","filing":"0001027035-26-000006","document":"wk-form4a_1773094322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000102703526000006/wk-form4a_1773094322.xml","form_type":"4/A","original_submission_date":"2025-03-05"}},{"id":878064,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-27T21:44:06.000Z","date":"2026-02-05","kind":"purchase","planned":false,"acquired":true,"shares":294117,"price":17,"value":4999989.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment is being filed to correct the nature of the indirect ownership reported in the Form 4 filed on February 5, 2026 (Original Form 4). The Original Form 4 inadvertently misstated that 294,117 shares of Common Stock were indirectly acquired by the Reporting Person through J.W. Childs Associates (FL), L.P. However, as reflected in this amendment, 294,117 shares of Common Stock were indirectly acquired by the Reporting Person through the John W. Childs 2013 Revocable Trust, and no shares of Common Stock were indirectly acquired by the Reporting Person through J.W. Childs Associates (FL), L.P."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amendment is being filed to correct the nature of the indirect ownership reported in the Form 4 filed on February 5, 2026 (Original Form 4). The Original Form 4 inadvertently misstated that 294,117 shares of Common Stock were indirectly acquired by the Reporting Person through J.W. Childs Associates (FL), L.P. However, as reflected in this amendment, 294,117 shares of Common Stock were indirectly acquired by the Reporting Person through the John W. Childs 2013 Revocable Trust, and no shares of Common Stock were indirectly acquired by the Reporting Person through J.W. Childs Associates (FL), L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This amendment is being filed to correct the nature of the indirect ownership reported in the Form 4 filed on February 5, 2026 (Original Form 4). The Original Form 4 inadvertently misstated that 294,117 shares of Common Stock were indirectly acquired by the Reporting Person through J.W. Childs Associates (FL), L.P. However, as reflected in this amendment, 294,117 shares of Common Stock were indirectly acquired by the Reporting Person through the John W. Childs 2013 Revocable Trust, and no shares of Common Stock were indirectly acquired by the Reporting Person through J.W. Childs Associates (FL), L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by the John W. Childs 2013 Revocable Trust. The Reporting Person is Trustee of the John W. Childs 2013 Revocable Trust and may be deemed to hold voting and dispositive power with respect to these securities."}],"balance_after":294117,"source":{"system":"sec-edgar","filing":"0001027035-26-000004","document":"wk-form4a_1772228643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000102703526000004/wk-form4a_1772228643.xml","form_type":"4/A","original_submission_date":"2026-02-05"}},{"id":918139,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-06T00:04:00.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":51525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option shall be fully vested and exercisable on February 3, 2027, the first anniversary of the vesting commencement date."}],"balance_after":51525,"derivative":{"exercise_price":17,"expiration_date":"2036-02-03","underlying":"Common Stock","underlying_shares":51525},"source":{"system":"sec-edgar","filing":"0001628280-26-005906","document":"wk-form4_1770336237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000162828026005906/wk-form4_1770336237.xml","form_type":"4"}},{"id":918138,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2026-02-06T00:04:00.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":false,"shares":520758,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by J.W. Childs Associates (FL), L.P. John W. Childs 2013 Revocable Trust is the sole owner of J.W. Childs Associates (FL), L.P. The Reporting Person, a member of the board of directors of the Issuer, is Trustee of John W. Childs 2013 Revocable Trust and may be deemed to hold voting and dispositive power with respect to these securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":520758},"source":{"system":"sec-edgar","filing":"0001628280-26-005906","document":"wk-form4_1770336237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000162828026005906/wk-form4_1770336237.xml","form_type":"4"}},{"id":918137,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2026-02-06T00:04:00.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":false,"shares":906862,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by J.W. Childs Associates (FL), L.P. John W. Childs 2013 Revocable Trust is the sole owner of J.W. Childs Associates (FL), L.P. The Reporting Person, a member of the board of directors of the Issuer, is Trustee of John W. Childs 2013 Revocable Trust and may be deemed to hold voting and dispositive power with respect to these securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":906862},"source":{"system":"sec-edgar","filing":"0001628280-26-005906","document":"wk-form4_1770336237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000162828026005906/wk-form4_1770336237.xml","form_type":"4"}},{"id":918136,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2026-02-06T00:04:00.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":false,"shares":480269,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (\"Common Stock\"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (\"Common Stock\"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (\"Common Stock\"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (\"Common Stock\"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by J.W. Childs Associates (FL), L.P. John W. Childs 2013 Revocable Trust is the sole owner of J.W. Childs Associates (FL), L.P. The Reporting Person, a member of the board of directors of the Issuer, is Trustee of John W. Childs 2013 Revocable Trust and may be deemed to hold voting and dispositive power with respect to these securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":480269},"source":{"system":"sec-edgar","filing":"0001628280-26-005906","document":"wk-form4_1770336237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000162828026005906/wk-form4_1770336237.xml","form_type":"4"}},{"id":918135,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T00:04:00.000Z","date":"2026-02-05","kind":"purchase","planned":false,"acquired":true,"shares":294117,"price":17,"value":4999989.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by J.W. Childs Associates (FL), L.P. John W. Childs 2013 Revocable Trust is the sole owner of J.W. Childs Associates (FL), L.P. The Reporting Person, a member of the board of directors of the Issuer, is Trustee of John W. Childs 2013 Revocable Trust and may be deemed to hold voting and dispositive power with respect to these securities."}],"balance_after":2202006,"source":{"system":"sec-edgar","filing":"0001628280-26-005906","document":"wk-form4_1770336237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000162828026005906/wk-form4_1770336237.xml","form_type":"4"}},{"id":918134,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T00:04:00.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":true,"shares":520758,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by J.W. Childs Associates (FL), L.P. John W. Childs 2013 Revocable Trust is the sole owner of J.W. Childs Associates (FL), L.P. The Reporting Person, a member of the board of directors of the Issuer, is Trustee of John W. Childs 2013 Revocable Trust and may be deemed to hold voting and dispositive power with respect to these securities."}],"balance_after":1907889,"source":{"system":"sec-edgar","filing":"0001628280-26-005906","document":"wk-form4_1770336237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000162828026005906/wk-form4_1770336237.xml","form_type":"4"}},{"id":918133,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T00:04:00.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":true,"shares":906862,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by J.W. Childs Associates (FL), L.P. John W. Childs 2013 Revocable Trust is the sole owner of J.W. Childs Associates (FL), L.P. The Reporting Person, a member of the board of directors of the Issuer, is Trustee of John W. Childs 2013 Revocable Trust and may be deemed to hold voting and dispositive power with respect to these securities."}],"balance_after":1387131,"source":{"system":"sec-edgar","filing":"0001628280-26-005906","document":"wk-form4_1770336237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000162828026005906/wk-form4_1770336237.xml","form_type":"4"}},{"id":918132,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T00:04:00.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":true,"shares":480269,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (\"Common Stock\"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (\"Common Stock\"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by J.W. Childs Associates (FL), L.P. John W. Childs 2013 Revocable Trust is the sole owner of J.W. Childs Associates (FL), L.P. The Reporting Person, a member of the board of directors of the Issuer, is Trustee of John W. Childs 2013 Revocable Trust and may be deemed to hold voting and dispositive power with respect to these securities."}],"balance_after":480269,"source":{"system":"sec-edgar","filing":"0001628280-26-005906","document":"wk-form4_1770336237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000162828026005906/wk-form4_1770336237.xml","form_type":"4"}},{"id":998182,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-11-17T12:30:45.000Z","date":"2025-11-13","kind":"purchase","planned":false,"acquired":true,"shares":3333333,"price":7.5,"value":24999997.5,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."}],"balance_after":5653904,"source":{"system":"sec-edgar","filing":"0001027035-25-000004","document":"wk-form4_1763382643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000102703525000004/wk-form4_1763382643.xml","form_type":"4"}},{"id":1156505,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-05-07T21:12:36.000Z","date":"2025-05-05","kind":"grant","planned":false,"acquired":true,"shares":31716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) May 5, 2026 or (b) the date of the 2026 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":31716,"derivative":{"exercise_price":22.62,"expiration_date":"2035-05-05","underlying":"Common Shares","underlying_shares":31716},"source":{"system":"sec-edgar","filing":"0001935979-25-000042","document":"wk-form4_1746652349.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000193597925000042/wk-form4_1746652349.xml","form_type":"4"}},{"id":1223902,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-03-05T12:01:52.000Z","date":"2025-03-04","kind":"purchase","planned":false,"acquired":true,"shares":900,"price":30.7261,"value":27653.49,"ownership":{"direct":false,"nature":"By 1994 Charitable Remainder Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.54 - $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":25291,"source":{"system":"sec-edgar","filing":"0001935979-25-000018","document":"wk-form4_1741176105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000193597925000018/wk-form4_1741176105.xml","form_type":"4"}},{"id":1223901,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-03-05T12:01:52.000Z","date":"2025-03-04","kind":"purchase","planned":false,"acquired":true,"shares":3400,"price":30.7261,"value":104468.74,"ownership":{"direct":false,"nature":"By 2013 Charitable Remainder Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.54 - $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":76570,"source":{"system":"sec-edgar","filing":"0001935979-25-000018","document":"wk-form4_1741176105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000193597925000018/wk-form4_1741176105.xml","form_type":"4"}},{"id":1223900,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-03-05T12:01:52.000Z","date":"2025-03-04","kind":"purchase","planned":false,"acquired":true,"shares":3400,"price":30.7261,"value":104468.74,"ownership":{"direct":false,"nature":"By 2007 Charitable Remainder Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.54 - $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":24452,"source":{"system":"sec-edgar","filing":"0001935979-25-000018","document":"wk-form4_1741176105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000193597925000018/wk-form4_1741176105.xml","form_type":"4"}},{"id":1223899,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-03-05T12:01:52.000Z","date":"2025-03-04","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":30.3859,"value":759647.5,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.17 - $30.48, inclusive. The Reporting Person undertakes\nto provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each\nseparate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2320571,"source":{"system":"sec-edgar","filing":"0001935979-25-000018","document":"wk-form4_1741176105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000193597925000018/wk-form4_1741176105.xml","form_type":"4"}},{"id":1223898,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-03-05T11:59:47.000Z","date":"2024-04-22","kind":"purchase","planned":false,"acquired":true,"shares":73170,"price":41,"value":2999970.0,"ownership":{"direct":false,"nature":"By 2013 Charitable Remainder Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."},{"field":"shares","element":"transactionShares","label":"F2","text":"This amendment is being filed to correct the nature of the indirect ownership reported in the Form 4 filed on April 23, 2024 (the \"Original Form 4\"). The Original Form 4 inadvertently misstated that 73,170 Common Shares were indirectly acquired by the Reporting Person through the John W Childs 2013 Revocable Trust. However, as reflected in this amendment, 73,170 Common Shares were indirectly acquired by the Reporting Person through the 2013 Charitable Remainder Trust, and no Common Shares were indirectly acquired by the Reporting Person through the John W Childs 2013 Revocable Trust."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amendment is being filed to correct the nature of the indirect ownership reported in the Form 4 filed on April 23, 2024 (the \"Original Form 4\"). The Original Form 4 inadvertently misstated that 73,170 Common Shares were indirectly acquired by the Reporting Person through the John W Childs 2013 Revocable Trust. However, as reflected in this amendment, 73,170 Common Shares were indirectly acquired by the Reporting Person through the 2013 Charitable Remainder Trust, and no Common Shares were indirectly acquired by the Reporting Person through the John W Childs 2013 Revocable Trust."}],"balance_after":73170,"source":{"system":"sec-edgar","filing":"0001935979-25-000017","document":"wk-form4a_1741175981.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000193597925000017/wk-form4a_1741175981.xml","form_type":"4/A","original_submission_date":"2024-04-23"}},{"id":1320029,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-12-31T12:00:14.000Z","date":"2024-12-30","kind":"purchase","planned":false,"acquired":true,"shares":29000,"price":35.9446,"value":1042393.4,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $35.57 - $36.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2368741,"source":{"system":"sec-edgar","filing":"0001935979-24-000088","document":"wk-form4_1735646406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000193597924000088/wk-form4_1735646406.xml","form_type":"4"}},{"id":1392523,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-10-03T11:01:22.000Z","date":"2024-10-02","kind":"purchase","planned":false,"acquired":true,"shares":21052,"price":47.5,"value":999970.0,"ownership":{"direct":false,"nature":"By 2007 Charitable Remainder Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."}],"balance_after":21052,"source":{"system":"sec-edgar","filing":"0001935979-24-000078","document":"wk-form4_1727953276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000193597924000078/wk-form4_1727953276.xml","form_type":"4"}},{"id":1451401,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-07-19T12:56:50.000Z","date":"2024-07-18","kind":"purchase","planned":false,"acquired":true,"shares":28400,"price":35.6684,"value":1012982.56,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $35.485 - $35.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2339741,"source":{"system":"sec-edgar","filing":"0001562180-24-005805","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218024005805/primarydocument.xml","form_type":"4"}},{"id":1497006,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-05-31T13:04:05.000Z","date":"2024-05-30","kind":"purchase","planned":false,"acquired":true,"shares":28000,"price":35.58,"value":996240.0,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $35.29 - $35.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2311341,"source":{"system":"sec-edgar","filing":"0001562180-24-004529","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218024004529/primarydocument.xml","form_type":"4"}},{"id":1517986,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-05-14T11:30:29.000Z","date":"2024-05-13","kind":"purchase","planned":false,"acquired":true,"shares":28500,"price":35.1744,"value":1002470.4,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $35.00 - $35.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2283341,"source":{"system":"sec-edgar","filing":"0001562180-24-004011","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218024004011/primarydocument.xml","form_type":"4"}},{"id":1530932,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-02T23:32:56.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":16592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 30, 2025 or (b) the date of the 2025 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":16592,"derivative":{"exercise_price":38.8,"expiration_date":"2034-04-30","underlying":"Common Shares","underlying_shares":16592},"source":{"system":"sec-edgar","filing":"0001562180-24-003750","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218024003750/primarydocument.xml","form_type":"4"}},{"id":1537056,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-04-23T11:54:20.000Z","date":"2024-04-22","kind":"purchase","planned":false,"acquired":true,"shares":73170,"price":41,"value":2999970.0,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."}],"balance_after":2254841,"source":{"system":"sec-edgar","filing":"0001562180-24-003494","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218024003494/primarydocument.xml","form_type":"4"}},{"id":1537055,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-04-23T11:54:20.000Z","date":"2024-04-22","kind":"purchase","planned":false,"acquired":true,"shares":97560,"price":41,"value":3999960.0,"ownership":{"direct":false,"nature":"By 2021 B-H Charitable Remainder Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."}],"balance_after":4096512,"source":{"system":"sec-edgar","filing":"0001562180-24-003494","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218024003494/primarydocument.xml","form_type":"4"}},{"id":1537054,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-04-23T11:54:20.000Z","date":"2024-04-22","kind":"purchase","planned":false,"acquired":true,"shares":24391,"price":41,"value":1000031.0,"ownership":{"direct":false,"nature":"By 1994 Charitable Remainder Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."}],"balance_after":24391,"source":{"system":"sec-edgar","filing":"0001562180-24-003494","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218024003494/primarydocument.xml","form_type":"4"}},{"id":1547138,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-04-06T00:21:33.000Z","date":"2024-04-05","kind":"grant","planned":false,"acquired":true,"shares":2091,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a merger transaction, consummated on January 8, 2024, 48,505 common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3. The issuer subsequently determined that an error was made in the calculation of the number of common shares issued and on April 5, 2024, an additional 2,091 common shares of the Issuer were received by the Reporting Person related to the exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a merger transaction, consummated on January 8, 2024, 48,505 common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3. The issuer subsequently determined that an error was made in the calculation of the number of common shares issued and on April 5, 2024, an additional 2,091 common shares of the Issuer were received by the Reporting Person related to the exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3."}],"balance_after":2181671,"source":{"system":"sec-edgar","filing":"0001562180-24-003337","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218024003337/primarydocument.xml","form_type":"4"}},{"id":1587676,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-03-08T23:35:38.000Z","date":"2024-03-08","kind":"grant","planned":false,"acquired":true,"shares":19412,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an agreement and plan of merger, dated as of January 7, 2024, common shares of the Issuer were issued to the Reporting Person on March 8, 2024.  The acquisition of the acquired company pursuant to the agreement and plan of merger and the issuance of common shares of the Issuer to the Reporting Person in connection therewith were approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to an agreement and plan of merger, dated as of January 7, 2024, common shares of the Issuer were issued to the Reporting Person on March 8, 2024.  The acquisition of the acquired company pursuant to the agreement and plan of merger and the issuance of common shares of the Issuer to the Reporting Person in connection therewith were approved by the Board of the Issuer pursuant to Rule 16b-3."}],"balance_after":2179580,"source":{"system":"sec-edgar","filing":"0001562180-24-002510","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218024002510/primarydocument.xml","form_type":"4"}},{"id":1681885,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-01-11T02:11:22.000Z","date":"2024-01-08","kind":"other","planned":false,"acquired":true,"shares":48505,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a merger transaction, consummated on January 8, 2024, common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a merger transaction, consummated on January 8, 2024, common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3."}],"balance_after":2160168,"source":{"system":"sec-edgar","filing":"0001562180-24-000427","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218024000427/primarydocument.xml","form_type":"4"}},{"id":1762884,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-10-10T23:07:33.000Z","date":"2023-10-05","kind":"purchase","planned":false,"acquired":true,"shares":136545,"price":22,"value":3003990.0,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."}],"balance_after":2111663,"source":{"system":"sec-edgar","filing":"0001562180-23-007253","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218023007253/primarydocument.xml","form_type":"4"}},{"id":1762883,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-10-10T23:07:33.000Z","date":"2023-10-05","kind":"purchase","planned":false,"acquired":true,"shares":318000,"price":22,"value":6996000.0,"ownership":{"direct":false,"nature":"By 2021 B-H Charitable Remainder Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."}],"balance_after":3998952,"source":{"system":"sec-edgar","filing":"0001562180-23-007253","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218023007253/primarydocument.xml","form_type":"4"}},{"id":1792185,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-08-31T12:56:02.000Z","date":"2023-08-30","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":18.4436,"value":922180.0,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"balance_after":1975118,"source":{"system":"sec-edgar","filing":"0001562180-23-006632","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218023006632/primarydocument.xml","form_type":"4"}},{"id":1814094,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-08-07T11:29:08.000Z","date":"2023-08-04","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":19.7843,"value":1978430.0,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"balance_after":1925118,"source":{"system":"sec-edgar","filing":"0001562180-23-006204","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218023006204/primarydocument.xml","form_type":"4"}},{"id":1904750,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-04T21:51:36.000Z","date":"2023-05-02","kind":"grant","planned":false,"acquired":true,"shares":52906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) May 2, 2024 or (b) the date of the 2024  Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":52906,"derivative":{"exercise_price":13.2,"expiration_date":"2033-05-02","underlying":"Common Shares","underlying_shares":52906},"source":{"system":"sec-edgar","filing":"0001562180-23-003942","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218023003942/primarydocument.xml","form_type":"4"}},{"id":1942136,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-03-22T22:07:44.000Z","date":"2022-10-25","kind":"purchase","planned":false,"acquired":true,"shares":1328867,"price":10.5,"value":13953103.5,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Common Shares acquired in an underwritten public offering."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amendment is being filed to correct the form of ownership reported in the Form 4 filed on October 26, 2022 (the \"Original Form 4\") and to correct the total amount of Common Shares beneficially owned by the Reporting Person reported in the Original Form 4. The Original Form 4 inadvertently misstated the amount of Common Shares beneficially owned by the Reporting Person; however, as reflected in this amendment, the total amount of Common Shares beneficially owned by the Reporting Person is 5,506,070 Common Shares. In addition, the Original Form 4 inadvertently misstated that 5,691,251 Common Shares were directly held by the Reporting Person. However, as reflected in this amendment, no Common Shares were directly held by the Reporting Person. Rather, 1,825,118 Common Shares were indirectly held by the Reporting Person through the John W Childs 2013 Revocable Trust and 3,680,952 Common Shares were indirectly held by the Reporting Person in the 2021 B-H Charitable Remainder Trust."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This amendment is being filed to correct the form of ownership reported in the Form 4 filed on October 26, 2022 (the \"Original Form 4\") and to correct the total amount of Common Shares beneficially owned by the Reporting Person reported in the Original Form 4. The Original Form 4 inadvertently misstated the amount of Common Shares beneficially owned by the Reporting Person; however, as reflected in this amendment, the total amount of Common Shares beneficially owned by the Reporting Person is 5,506,070 Common Shares. In addition, the Original Form 4 inadvertently misstated that 5,691,251 Common Shares were directly held by the Reporting Person. However, as reflected in this amendment, no Common Shares were directly held by the Reporting Person. Rather, 1,825,118 Common Shares were indirectly held by the Reporting Person through the John W Childs 2013 Revocable Trust and 3,680,952 Common Shares were indirectly held by the Reporting Person in the 2021 B-H Charitable Remainder Trust."}],"balance_after":1825118,"source":{"system":"sec-edgar","filing":"0001562180-23-003045","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218023003045/primarydocument.xml","form_type":"4/A","original_submission_date":"2022-10-26"}},{"id":1942135,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-03-22T22:07:44.000Z","date":"2022-10-25","kind":"purchase","planned":false,"acquired":true,"shares":2380952,"price":10.5,"value":24999996.0,"ownership":{"direct":false,"nature":"By 2021 B-H Charitable Remainder Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Common Shares acquired in an underwritten public offering."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amendment is being filed to correct the form of ownership reported in the Form 4 filed on October 26, 2022 (the \"Original Form 4\") and to correct the total amount of Common Shares beneficially owned by the Reporting Person reported in the Original Form 4. The Original Form 4 inadvertently misstated the amount of Common Shares beneficially owned by the Reporting Person; however, as reflected in this amendment, the total amount of Common Shares beneficially owned by the Reporting Person is 5,506,070 Common Shares. In addition, the Original Form 4 inadvertently misstated that 5,691,251 Common Shares were directly held by the Reporting Person. However, as reflected in this amendment, no Common Shares were directly held by the Reporting Person. Rather, 1,825,118 Common Shares were indirectly held by the Reporting Person through the John W Childs 2013 Revocable Trust and 3,680,952 Common Shares were indirectly held by the Reporting Person in the 2021 B-H Charitable Remainder Trust."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This amendment is being filed to correct the form of ownership reported in the Form 4 filed on October 26, 2022 (the \"Original Form 4\") and to correct the total amount of Common Shares beneficially owned by the Reporting Person reported in the Original Form 4. The Original Form 4 inadvertently misstated the amount of Common Shares beneficially owned by the Reporting Person; however, as reflected in this amendment, the total amount of Common Shares beneficially owned by the Reporting Person is 5,506,070 Common Shares. In addition, the Original Form 4 inadvertently misstated that 5,691,251 Common Shares were directly held by the Reporting Person. However, as reflected in this amendment, no Common Shares were directly held by the Reporting Person. Rather, 1,825,118 Common Shares were indirectly held by the Reporting Person through the John W Childs 2013 Revocable Trust and 3,680,952 Common Shares were indirectly held by the Reporting Person in the 2021 B-H Charitable Remainder Trust."}],"balance_after":3680952,"source":{"system":"sec-edgar","filing":"0001562180-23-003045","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218023003045/primarydocument.xml","form_type":"4/A","original_submission_date":"2022-10-26"}},{"id":2131837,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-26T22:22:03.000Z","date":"2022-10-25","kind":"purchase","acquired":true,"shares":3900000,"price":10.5,"value":40950000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."}],"balance_after":5691251,"source":{"system":"sec-edgar","filing":"0001562180-22-007334","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218022007334/primarydocument.xml","form_type":"4"}},{"id":2142706,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-06T01:44:52.000Z","date":"2022-10-05","kind":"purchase","acquired":true,"shares":32841,"price":9.6953,"value":318403.3473,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.46 - $9.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":1791251,"source":{"system":"sec-edgar","filing":"0001562180-22-007104","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218022007104/primarydocument.xml","form_type":"4"}},{"id":2142705,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-06T01:44:52.000Z","date":"2022-10-05","kind":"purchase","acquired":true,"shares":241300,"price":8.8801,"value":2142768.13,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.45 - $9.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":1758410,"source":{"system":"sec-edgar","filing":"0001562180-22-007104","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218022007104/primarydocument.xml","form_type":"4"}},{"id":2142708,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-06T01:35:56.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This amendment is being filed to correct the form of ownership reported in the Form 4 filed on October 5, 2022 (the \"Original Form 4\"). The Original Form 4 inadvertently incorrectly reported that all Common Shares acquired were directly held by the Reporting Person; however, as reflected in this amendment, a portion of the Shares acquired were indirectly held by the Reporting Person in the John W. Childs 2013 Revocable Trust. There were no other changes made to the information in the Original Filing."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001562180-22-007102","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218022007102/primarydocument.xml","form_type":"4/A","original_submission_date":"2022-10-05"}},{"id":2142707,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-06T01:35:56.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":1512500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares of the Issuer (\"Common Shares\") acquired by the Reporting Person in a pro rata distribution by Biohaven Pharmaceutical Holding Company Ltd.. (\"RemainCo\") to holders of its common shares (the \"Distribution\") pursuant to the Separation and Distribution Agreement (the \"Separation Agreement\"), dated as of May 9, 2022, by and among RemainCo, the Issuer, and Pfizer Inc. (\"Pfizer\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This amendment is being filed to correct the form of ownership reported in the Form 4 filed on October 5, 2022 (the \"Original Form 4\"). The Original Form 4 inadvertently incorrectly reported that all Common Shares acquired were directly held by the Reporting Person; however, as reflected in this amendment, a portion of the Shares acquired were indirectly held by the Reporting Person in the John W. Childs 2013 Revocable Trust. There were no other changes made to the information in the Original Filing."}],"balance_after":1517110,"source":{"system":"sec-edgar","filing":"0001562180-22-007102","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218022007102/primarydocument.xml","form_type":"4/A","original_submission_date":"2022-10-05"}},{"id":2142704,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:37:51.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option vest in four equal installments on October 3, 2022, 2023, 2024, and 2025, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":125000,"derivative":{"exercise_price":7,"expiration_date":"2032-10-04","underlying":"Common Shares","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001562180-22-007078","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218022007078/primarydocument.xml","form_type":"4"}},{"id":2142703,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:37:51.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":5998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":0,"derivative":{"exercise_price":3.56,"expiration_date":"2031-05-05","underlying":"Common Shares","underlying_shares":5998},"source":{"system":"sec-edgar","filing":"0001562180-22-007078","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218022007078/primarydocument.xml","form_type":"4"}},{"id":2142702,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:37:51.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":4119,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":0,"derivative":{"exercise_price":4.84,"expiration_date":"2032-04-28","underlying":"Common Shares","underlying_shares":4119},"source":{"system":"sec-edgar","filing":"0001562180-22-007078","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218022007078/primarydocument.xml","form_type":"4"}},{"id":2142701,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:37:51.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":5998,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"shares","element":"transactionShares","label":"F3","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":5998,"derivative":{"exercise_price":3.56,"expiration_date":"2031-05-05","underlying":"Common Shares","underlying_shares":5998},"source":{"system":"sec-edgar","filing":"0001562180-22-007078","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218022007078/primarydocument.xml","form_type":"4"}},{"id":2142700,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:37:51.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":4119,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"shares","element":"transactionShares","label":"F3","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":4119,"derivative":{"exercise_price":4.84,"expiration_date":"2032-04-28","underlying":"Common Shares","underlying_shares":4119},"source":{"system":"sec-edgar","filing":"0001562180-22-007078","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218022007078/primarydocument.xml","form_type":"4"}},{"id":2142699,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-05T21:37:51.000Z","date":"2022-10-03","kind":"tax_withholding","acquired":false,"shares":5507,"price":7.5,"value":41302.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer in connection with share settlement to cover the cost of the stock options."}],"balance_after":1522110,"source":{"system":"sec-edgar","filing":"0001562180-22-007078","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218022007078/primarydocument.xml","form_type":"4"}},{"id":2142698,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-05T21:37:51.000Z","date":"2022-10-03","kind":"exercise","acquired":true,"shares":5998,"price":3.56,"value":21352.88,"ownership":{"direct":true},"balance_after":1527617,"source":{"system":"sec-edgar","filing":"0001562180-22-007078","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218022007078/primarydocument.xml","form_type":"4"}},{"id":2142697,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-05T21:37:51.000Z","date":"2022-10-03","kind":"exercise","acquired":true,"shares":4119,"price":4.84,"value":19935.96,"ownership":{"direct":true},"balance_after":1521619,"source":{"system":"sec-edgar","filing":"0001562180-22-007078","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218022007078/primarydocument.xml","form_type":"4"}},{"id":2142696,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-05T21:37:51.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":1517500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares of the Issuer (\"Common Shares\") acquired by the Reporting Person in a pro rata distribution by Biohaven Pharmaceutical Holding Company Ltd.. (\"RemainCo\") to holders of its common shares (the \"Distribution\") pursuant to the Separation and Distribution Agreement (the \"Separation Agreement\"), dated as of May 9, 2022, by and among RemainCo, the Issuer, and Pfizer Inc. (\"Pfizer\")."}],"balance_after":1517500,"source":{"system":"sec-edgar","filing":"0001562180-22-007078","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218022007078/primarydocument.xml","form_type":"4"}},{"id":2147840,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-04T00:29:12.000Z","date":"2022-10-03","kind":"disposition_to_issuer","acquired":false,"shares":11996,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"shares","element":"transactionShares","label":"F3","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":70.17,"expiration_date":"2031-05-05","underlying":"Common Shares","underlying_shares":11996},"source":{"system":"sec-edgar","filing":"0001562180-22-006964","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218022006964/primarydocument.xml","form_type":"4"}},{"id":2147839,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-04T00:29:12.000Z","date":"2022-10-03","kind":"disposition_to_issuer","acquired":false,"shares":8239,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"shares","element":"transactionShares","label":"F3","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"In connection with the Distribution, each outstanding option to purchase common shares of the Issuer was adjusted such that such option became an option to acquire SpinCo common shares and an option to acquire Common Shares (each such option, a \"Post-Spin Issuer Option\"). At the effective time of the Merger, each outstanding Post-Spin Issuer Option was automatically cancelled in exchange for the right to receive (without interest) an amount in cash equal to the product of (i) the excess, if any, of the Merger Consideration over the exercise price per Common Share of such Post-Spin Issuer Option and (ii) the number of Common Shares subject to such Post-Spin Issuer Option, less any withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":95.33,"expiration_date":"2032-04-28","underlying":"Common Shares","underlying_shares":8239},"source":{"system":"sec-edgar","filing":"0001562180-22-006964","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218022006964/primarydocument.xml","form_type":"4"}},{"id":2147838,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-04T00:29:12.000Z","date":"2022-10-03","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":148.5,"value":1485000.0,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Under the Agreement and Plan of Merger, dated as of May 9, 2022 (the \"Merger Agreement\"), by and among the Issuer, Pfizer Inc. (\"Pfizer\") and a wholly owned subsidiary of Pfizer (\"Merger Sub\"), following satisfaction or waiver of the closing conditions set forth in the Merger Agreement, on October 3, 2022 Merger Sub merged with and into the Issuer with the Issuer surviving as the surviving company (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In the Merger, each common share of the Issuer (each, a \"Common Share\") outstanding immediately prior to the effective time of the Merger (other than certain excluded shares pursuant to the terms of the Merger Agreement), was converted into the right to receive the merger consideration in cash of $148.50, without interest, less any withholding taxes (the \"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-22-006964","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218022006964/primarydocument.xml","form_type":"4"}},{"id":2147837,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-04T00:29:12.000Z","date":"2022-10-03","kind":"disposition_to_issuer","acquired":false,"shares":3025001,"price":148.5,"value":449212648.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Under the Agreement and Plan of Merger, dated as of May 9, 2022 (the \"Merger Agreement\"), by and among the Issuer, Pfizer Inc. (\"Pfizer\") and a wholly owned subsidiary of Pfizer (\"Merger Sub\"), following satisfaction or waiver of the closing conditions set forth in the Merger Agreement, on October 3, 2022 Merger Sub merged with and into the Issuer with the Issuer surviving as the surviving company (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In the Merger, each common share of the Issuer (each, a \"Common Share\") outstanding immediately prior to the effective time of the Merger (other than certain excluded shares pursuant to the terms of the Merger Agreement), was converted into the right to receive the merger consideration in cash of $148.50, without interest, less any withholding taxes (the \"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-22-006964","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218022006964/primarydocument.xml","form_type":"4"}},{"id":2288110,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-30T01:02:08.000Z","date":"2022-04-28","kind":"grant","acquired":true,"shares":8239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2023 or (b) the date of the 2023 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":8239,"derivative":{"exercise_price":97.74,"expiration_date":"2032-04-27","underlying":"Common Shares","underlying_shares":8239},"source":{"system":"sec-edgar","filing":"0001562180-22-003586","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218022003586/primarydocument.xml","form_type":"4"}},{"id":2508386,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-18T00:03:51.000Z","date":"2021-11-15","kind":"exercise","acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":47.1,"exercise_date":"2021-04-30","expiration_date":"2030-04-29","underlying":"Common Shares","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001562180-21-007139","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218021007139/primarydocument.xml","form_type":"4"}},{"id":2508385,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-18T00:03:51.000Z","date":"2021-11-15","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option vested as to 25% of the shares on April 6, 2017, and the remainder vested in 3 equal installments on the first, second and third anniversaries of the grant date."}],"balance_after":0,"derivative":{"exercise_price":10.82,"expiration_date":"2027-04-05","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-21-007139","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218021007139/primarydocument.xml","form_type":"4"}},{"id":2508384,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-18T00:03:51.000Z","date":"2021-11-15","kind":"exercise","acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":61.76,"exercise_date":"2020-04-30","expiration_date":"2029-05-20","underlying":"Common Shares","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001562180-21-007139","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218021007139/primarydocument.xml","form_type":"4"}},{"id":2508383,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-18T00:03:51.000Z","date":"2021-11-15","kind":"exercise","acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":28.76,"exercise_date":"2019-05-01","expiration_date":"2028-04-30","underlying":"Common Shares","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001562180-21-007139","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218021007139/primarydocument.xml","form_type":"4"}},{"id":2508382,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-18T00:03:51.000Z","date":"2021-11-15","kind":"exercise","acquired":false,"shares":37700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vested as to 25% of the shares on December 15, 2016, and the remainder vested in 3 equal installments on the first, second and third anniversaries of the grant date."}],"balance_after":0,"derivative":{"exercise_price":9.29,"expiration_date":"2026-12-14","underlying":"Common Shares","underlying_shares":37700},"source":{"system":"sec-edgar","filing":"0001562180-21-007139","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218021007139/primarydocument.xml","form_type":"4"}},{"id":2508381,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-18T00:03:51.000Z","date":"2021-11-15","kind":"exercise","acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vested as to 25% of the shares on October 23, 2015, and the remainder vested in 3 equal installments on the first, second and third anniversaries of the grant date."}],"balance_after":0,"derivative":{"exercise_price":5.6,"expiration_date":"2025-10-22","underlying":"Common Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001562180-21-007139","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218021007139/primarydocument.xml","form_type":"4"}},{"id":2508380,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-18T00:03:51.000Z","date":"2021-11-15","kind":"exercise","acquired":false,"shares":212500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vested as to 25% of the shares on November 26, 2014, and the remainder vested in 3 equal installments on the first, second and third anniversaries of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0.61,"expiration_date":"2024-11-25","underlying":"Common Shares","underlying_shares":212500},"source":{"system":"sec-edgar","filing":"0001562180-21-007139","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218021007139/primarydocument.xml","form_type":"4"}},{"id":2508379,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-11-18T00:03:51.000Z","date":"2021-11-15","kind":"exercise","acquired":true,"shares":18000,"price":47.1,"value":847800.0,"ownership":{"direct":true},"balance_after":3025001,"source":{"system":"sec-edgar","filing":"0001562180-21-007139","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218021007139/primarydocument.xml","form_type":"4"}},{"id":2508378,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-11-18T00:03:51.000Z","date":"2021-11-15","kind":"exercise","acquired":true,"shares":20000,"price":10.82,"value":216400.0,"ownership":{"direct":true},"balance_after":3007001,"source":{"system":"sec-edgar","filing":"0001562180-21-007139","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218021007139/primarydocument.xml","form_type":"4"}},{"id":2508377,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-11-18T00:03:51.000Z","date":"2021-11-15","kind":"exercise","acquired":true,"shares":18000,"price":61.76,"value":1111680.0,"ownership":{"direct":true},"balance_after":2987001,"source":{"system":"sec-edgar","filing":"0001562180-21-007139","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218021007139/primarydocument.xml","form_type":"4"}},{"id":2508376,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-11-18T00:03:51.000Z","date":"2021-11-15","kind":"exercise","acquired":true,"shares":18000,"price":28.76,"value":517680.0,"ownership":{"direct":true},"balance_after":2969001,"source":{"system":"sec-edgar","filing":"0001562180-21-007139","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218021007139/primarydocument.xml","form_type":"4"}},{"id":2508375,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-11-18T00:03:51.000Z","date":"2021-11-15","kind":"exercise","acquired":true,"shares":37700,"price":9.29,"value":350233.0,"ownership":{"direct":true},"balance_after":2951001,"source":{"system":"sec-edgar","filing":"0001562180-21-007139","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218021007139/primarydocument.xml","form_type":"4"}},{"id":2508374,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-11-18T00:03:51.000Z","date":"2021-11-15","kind":"exercise","acquired":true,"shares":150000,"price":5.6,"value":840000.0,"ownership":{"direct":true},"balance_after":2913301,"source":{"system":"sec-edgar","filing":"0001562180-21-007139","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218021007139/primarydocument.xml","form_type":"4"}},{"id":2508373,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-11-18T00:03:51.000Z","date":"2021-11-15","kind":"exercise","acquired":true,"shares":212500,"price":0.61,"value":129625.0,"ownership":{"direct":true},"balance_after":2763301,"source":{"system":"sec-edgar","filing":"0001562180-21-007139","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218021007139/primarydocument.xml","form_type":"4"}},{"id":2518305,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-11-10T23:19:09.000Z","date":"2021-11-10","kind":"purchase","acquired":true,"shares":1110,"price":123.2991,"value":136862.001,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $123.16 - $123.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2550801,"source":{"system":"sec-edgar","filing":"0001562180-21-006983","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218021006983/primarydocument.xml","form_type":"4"}},{"id":2518304,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-11-10T23:19:09.000Z","date":"2021-11-10","kind":"purchase","acquired":true,"shares":3890,"price":122.7455,"value":477479.995,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $122.45 - $123.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2549691,"source":{"system":"sec-edgar","filing":"0001562180-21-006983","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218021006983/primarydocument.xml","form_type":"4"}},{"id":2723690,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-07T20:34:39.000Z","date":"2021-05-05","kind":"grant","acquired":true,"shares":11996,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) May 5, 2022 or (b) the date of the 2022 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":11996,"derivative":{"exercise_price":71.94,"expiration_date":"2031-05-04","underlying":"Common Shares","underlying_shares":11996},"source":{"system":"sec-edgar","filing":"0001562180-21-003339","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218021003339/primarydocument.xml","form_type":"4"}},{"id":2783668,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-03-17T21:13:20.000Z","date":"2021-03-17","kind":"purchase","acquired":true,"shares":13157,"price":76,"value":999932.0,"ownership":{"direct":true},"balance_after":2545801,"source":{"system":"sec-edgar","filing":"0001562180-21-002300","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218021002300/primarydocument.xml","form_type":"4"}},{"id":2815477,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-03-04T02:22:57.000Z","date":"2021-03-02","kind":"purchase","acquired":true,"shares":10000,"price":85.137,"value":851370.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $84.93 - $85.335, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2532644,"source":{"system":"sec-edgar","filing":"0001562180-21-001959","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218021001959/primarydocument.xml","form_type":"4"}},{"id":2864127,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-02-13T02:51:04.000Z","date":"2021-01-25","kind":"other","acquired":true,"shares":5706,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of January 1, 2021, by and among Biohaven Pharmaceutical Holding Company Ltd., Biohaven Therapeutics Ltd., Kleo Acquisition, Inc., Kleo Pharmaceuticals, Inc. (\"Kleo\") and Shareholder Representative Services LLC, on January 25, 2021, common shares of the Issuer were received in exchange for shares of common stock of Kleo held by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of January 1, 2021, by and among Biohaven Pharmaceutical Holding Company Ltd., Biohaven Therapeutics Ltd., Kleo Acquisition, Inc., Kleo Pharmaceuticals, Inc. (\"Kleo\") and Shareholder Representative Services LLC, on January 25, 2021, common shares of the Issuer were received in exchange for shares of common stock of Kleo held by the Reporting Person."}],"balance_after":2522644,"source":{"system":"sec-edgar","filing":"0001562180-21-001147","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218021001147/primarydocument.xml","form_type":"4"}},{"id":2970158,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-11-24T01:40:37.000Z","date":"2020-11-23","kind":"purchase","acquired":true,"shares":5000,"price":89.5473,"value":447736.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $89.36- $90.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2516938,"source":{"system":"sec-edgar","filing":"0001562180-20-006851","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218020006851/primarydocument.xml","form_type":"4"}},{"id":3025237,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-09-23T01:51:49.000Z","date":"2020-09-21","kind":"purchase","acquired":true,"shares":3322,"price":59.25,"value":196828.5,"ownership":{"direct":true},"balance_after":2511938,"source":{"system":"sec-edgar","filing":"0001562180-20-006075","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218020006075/primarydocument.xml","form_type":"4"}},{"id":3032526,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-09-15T00:49:20.000Z","date":"2020-09-11","kind":"purchase","acquired":true,"shares":6678,"price":58.9973,"value":393983.9694,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $58.93 - $59.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2508616,"source":{"system":"sec-edgar","filing":"0001562180-20-005986","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218020005986/primarydocument.xml","form_type":"4"}},{"id":3060680,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-08-12T22:25:09.000Z","date":"2020-08-11","kind":"purchase","acquired":true,"shares":15129,"price":61.8741,"value":936093.2589,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $61.71 - $62.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2501938,"source":{"system":"sec-edgar","filing":"0001562180-20-005409","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218020005409/primarydocument.xml","form_type":"4"}},{"id":3060679,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-08-12T22:25:09.000Z","date":"2020-08-11","kind":"purchase","acquired":true,"shares":7271,"price":61.2801,"value":445567.6071,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $60.71 - $61.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2486809,"source":{"system":"sec-edgar","filing":"0001562180-20-005409","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218020005409/primarydocument.xml","form_type":"4"}},{"id":3060678,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-08-12T22:25:09.000Z","date":"2020-08-11","kind":"purchase","acquired":true,"shares":2600,"price":60.3169,"value":156823.94,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $59.69 - $60.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2479538,"source":{"system":"sec-edgar","filing":"0001562180-20-005409","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218020005409/primarydocument.xml","form_type":"4"}},{"id":3165634,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-02T01:14:45.000Z","date":"2020-04-30","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 30, 2021 or (b) the date of the 2021 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":18000,"derivative":{"exercise_price":47.1,"expiration_date":"2030-04-29","underlying":"Common Shares","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001562180-20-003256","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218020003256/primarydocument.xml","form_type":"4"}},{"id":3179916,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-04-09T01:42:18.000Z","date":"2020-04-07","kind":"sale","acquired":false,"shares":14734,"price":33.2645,"value":490119.143,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.11 - $33.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2476938,"source":{"system":"sec-edgar","filing":"0001562180-20-002967","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218020002967/primarydocument.xml","form_type":"4"}},{"id":3179915,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-04-09T01:42:18.000Z","date":"2020-04-07","kind":"sale","acquired":false,"shares":93268,"price":32.9173,"value":3070130.7364,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.11 - $33.105, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2491672,"source":{"system":"sec-edgar","filing":"0001562180-20-002967","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218020002967/primarydocument.xml","form_type":"4"}},{"id":3179914,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-04-09T01:42:18.000Z","date":"2020-04-07","kind":"sale","acquired":false,"shares":10908,"price":31.5545,"value":344196.486,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.095 - $32.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2584940,"source":{"system":"sec-edgar","filing":"0001562180-20-002967","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218020002967/primarydocument.xml","form_type":"4"}},{"id":3179913,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-04-09T01:42:18.000Z","date":"2020-04-07","kind":"sale","acquired":false,"shares":81090,"price":30.5412,"value":2476585.908,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.095 - $31.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2595848,"source":{"system":"sec-edgar","filing":"0001562180-20-002967","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218020002967/primarydocument.xml","form_type":"4"}},{"id":3179912,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-04-09T01:42:18.000Z","date":"2020-04-06","kind":"sale","acquired":false,"shares":5341,"price":31.7594,"value":169626.9554,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.70 - $31.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2676938,"source":{"system":"sec-edgar","filing":"0001562180-20-002967","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218020002967/primarydocument.xml","form_type":"4"}},{"id":3179911,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-04-09T01:42:18.000Z","date":"2020-04-06","kind":"sale","acquired":false,"shares":144659,"price":31.2273,"value":4517309.9907,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.70 - $31.6925, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2682279,"source":{"system":"sec-edgar","filing":"0001562180-20-002967","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218020002967/primarydocument.xml","form_type":"4"}},{"id":3478232,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-06-27T00:40:24.000Z","date":"2019-06-26","kind":"purchase","acquired":true,"shares":10000,"price":40.37,"value":403700.0,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-19-039192","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000120919119039192/doc4.xml","form_type":"4"}},{"id":3513885,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-23T22:36:20.000Z","date":"2019-05-21","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) May 21, 2020 or (b) the date of the 2020 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":18000,"derivative":{"exercise_price":61.76,"expiration_date":"2029-05-20","underlying":"Common Shares","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-19-032468","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000120919119032468/doc4.xml","form_type":"4"}},{"id":3561847,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Common Shares (Right to Buy)","published_at":"2019-04-05T21:53:40.000Z","date":"2019-03-22","kind":"exercise","acquired":false,"shares":107500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":9.29,"expiration_date":"2019-05-09","underlying":"Common Shares","underlying_shares":107500},"source":{"system":"sec-edgar","filing":"0001209191-19-023859","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000120919119023859/doc4.xml","form_type":"4"}},{"id":3561846,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-04-05T21:53:40.000Z","date":"2019-03-22","kind":"exercise","acquired":true,"shares":107500,"price":9.29,"value":998675.0,"ownership":{"direct":true},"balance_after":107500,"source":{"system":"sec-edgar","filing":"0001209191-19-023859","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000120919119023859/doc4.xml","form_type":"4"}},{"id":3948178,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-03T21:24:18.000Z","date":"2018-05-01","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) May 1, 2019 or (b) the date of the 2019 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":18000,"derivative":{"exercise_price":28.76,"expiration_date":"2028-04-30","underlying":"Common Shares","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-18-027730","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000120919118027730/doc4.xml","form_type":"4"}},{"id":4328701,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Shares","published_at":"2017-05-09T20:47:04.000Z","date":"2017-05-09","kind":"exercise","acquired":false,"shares":1035938,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the John W. Childs 2013 Revocable Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common shares, each Series A Preferred Share automatically converted into one common share of the Issuer.  The Series A Preferred Shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common shares, each Series A Preferred Share automatically converted into one common share of the Issuer.  The Series A Preferred Shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Effective immediately prior to the closing of the Issuer's initial public offering of its common shares, each Series A Preferred Share automatically converted into one common share of the Issuer.  The Series A Preferred Shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":1035938},"source":{"system":"sec-edgar","filing":"0001209191-17-030981","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000120919117030981/doc4.xml","form_type":"4"}},{"id":4328700,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2017-05-09T20:47:04.000Z","date":"2017-05-09","kind":"purchase","acquired":true,"shares":415000,"price":17,"value":7055000.0,"ownership":{"direct":false,"nature":"By the John W. Childs 2013 Revocable Trust"},"balance_after":2719438,"source":{"system":"sec-edgar","filing":"0001209191-17-030981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000120919117030981/doc4.xml","form_type":"4"}},{"id":4328699,"issuer":{"id":123269,"kind":"organization","name":"Biohaven Pharmaceutical Holding Co Ltd."},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2017-05-09T20:47:04.000Z","date":"2017-05-09","kind":"exercise","acquired":true,"shares":1035938,"ownership":{"direct":false,"nature":"By the John W. Childs 2013 Revocable Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares received upon conversion of Series A Preferred Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares received upon conversion of Series A Preferred Shares."}],"balance_after":2304438,"source":{"system":"sec-edgar","filing":"0001209191-17-030981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000120919117030981/doc4.xml","form_type":"4"}}],"next_cursor":"2017-05-09T20:47:04.000000Z,4328699"}